Align Technology (ALGN) Net Equity Issued and Repurchased (2009 - 2026)
Align Technology's (ALGN) quarterly Net Equity Issued and Repurchased came in at $11.7 million in Q1 2026, down 15.75% year-on-year from $13.9 million in Q1 2025, and up 49.46% on a QoQ basis from $7.8 million in Q3 2025.
Align Technology (ALGN) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has 18 years of Net Equity Issued and Repurchased data on file, last reported at $11.7 million in Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased fell 15.75% year-over-year to $11.7 million in Q1 2026; TTM through Mar 2026 was $19.6 million, a 21.3% decrease from a year earlier, with the FY2025 full-year figure at $21.7 million, down 13.97% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $11.7 million, up from $7.8 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for ALGN reached as high as $14.8 million in Q1 2022 and fell as low as $7.8 million in Q3 2025.
- Historically, Net Equity Issued and Repurchased has averaged $12.4 million across 5 years, with a median of $12.3 million in 2023.
- Across the five-year window, Net Equity Issued and Repurchased grew 12.9% in 2022 and declined 28.35% in 2025, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $11.3 million in 2022, then gained by 8.98% to $12.3 million in 2023, then decreased by 11.32% to $10.9 million in 2024, then dropped by 28.35% to $7.8 million in 2025, then jumped by 49.46% to $11.7 million in 2026.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $11.7 million in Q1 2026, $7.8 million in Q3 2025, and $13.9 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 7.43 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.72 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.72 Mn |
| Mar 31, 2026 | 11.72 Mn |
| Sep 30, 2025 | 7.84 Mn |
| Sep 30, 2025 | 7.84 Mn |
| Mar 31, 2025 | 13.91 Mn |
| Mar 31, 2025 | 13.91 Mn |
| Sep 30, 2024 | 10.94 Mn |
| Sep 30, 2024 | 10.94 Mn |
| Mar 31, 2024 | 14.34 Mn |
| Mar 31, 2024 | 14.34 Mn |
| Sep 30, 2023 | 12.34 Mn |
| Sep 30, 2023 | 12.34 Mn |
| Mar 31, 2023 | 14.26 Mn |
| Mar 31, 2023 | 14.26 Mn |
| Sep 30, 2022 | 11.32 Mn |
| Sep 30, 2022 | 11.32 Mn |
| Mar 31, 2022 | 14.83 Mn |
| Mar 31, 2022 | 14.83 Mn |
| Sep 30, 2021 | 12.49 Mn |
| Sep 30, 2021 | 12.49 Mn |